Cargando…
Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use
BACKGROUND: It has been suggested that bladder cancer can be divided into two molecular subtypes referred to as luminal and basal with distinct clinical behaviors and sensitivities to chemotherapy. We aimed to validate these subtypes in several clinical cohorts and identify signature immunohistochem...
Autores principales: | Dadhania, Vipulkumar, Zhang, Miao, Zhang, Li, Bondaruk, Jolanta, Majewski, Tadeusz, Siefker-Radtke, Arlene, Guo, Charles C., Dinney, Colin, Cogdell, David E., Zhang, Shizhen, Lee, Sangkyou, Lee, June G., Weinstein, John N., Baggerly, Keith, McConkey, David, Czerniak, Bogdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078592/ https://www.ncbi.nlm.nih.gov/pubmed/27612592 http://dx.doi.org/10.1016/j.ebiom.2016.08.036 |
Ejemplares similares
-
Assessment of Luminal and Basal Phenotypes in Bladder Cancer
por: Guo, Charles C., et al.
Publicado: (2020) -
Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer
por: Yang, Guoliang, et al.
Publicado: (2020) -
Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016) -
Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior
por: Mobley, Aaron, et al.
Publicado: (2017) -
In-Frame cDNA Library Combined with Protein Complementation Assay Identifies ARL11-Binding Partners
por: Lee, Sangkyou, et al.
Publicado: (2012)